Levaquin, Levofloxacin News

Dear Dr. Gott: I recently heard a statement on television made by an attorney with regard to Levaquin, causing tendon rupture and asking anyone who suffered with the problem to call a toll-free telephone number.

Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication.

Burkholderia mallei is a zoonotic gram negative bacterium which primarily infects solipeds but can cause lethal disease in humans if left untreated.

Abstract BACKGROUND: We investigated whether the use of respiratory fluoroquinolones was associated with better clinical outcomes compared with the use of macrolides and beta- lactams among adults with pneumonia.

Pneumococcal diseases remain a major cause of morbidity and mortality worldwide.

Daiichi Sankyo is suing 13 generic-drug companies for the substance patent and usage patent for Cravit tablets and fine granules , according to a company press release.

Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration approved TYGACIL , for the treatment of adult patients with community-acquired bacterial pneumonia caused by susceptible strains of indicated pathogens.

TOKYO, March 23, 2009 Daiichi Sankyo Company, Limited announced that it has brought patent infringement litigation against 13 generics companies for the substance patent and usage patent for Levofloxacin Hydrate* . Levofloxacin Hydrate broad-spectrum oral anti-bacterial agents originated by Daiichi Sankyo, has been marketed by the company in Japan ...

DRUG NEWS: Fluoroquinolone-induced tendinopathy On July 8, 2008, the FDA requested that the different manufacturers of fluoroquinolone antibiotics strengthen the warnings section in their prescribing ...

Abstract To facilitate optimal dosing regimen design, we previously developed a mathematical model using time-kill study data to predict the responses of Pseudomonas aeruginosa to various pharmacokinetic ...

Mpex Pharmaceuticals, Inc. today announced that it has completed a $27.5 million initial closing of a Series D financing led by Investor Growth Capital.

Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive final ...

When Dr. J.T. Cooper hobbles around his Marietta medical office, the boot brace on his right foot is a reminder of a danger posed by some of the most popular - and misprescribed - antibiotics on the market.

When Dr. J.T. Cooper hobbles around his Marietta medical office, the boot brace on his right foot is a reminder of a danger posed by some of the most popular - - and misprescribed - - antibiotics on the market.

China Sky One Medical, Inc. said its subsidiary, Heilongjiang Tianlong Pharmaceutical, received SFDA production approval for four newly developed drugs.

Abstract PURPOSE: The SIGNIFICANT trial reported a reduction in febrile episodes among 1,565 patients with solid cancers and lymphomas receiving cyclical, myelosuppressive chemotherapy in a randomized, ...

Rib-X Pharmaceuticals, Inc. , a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced ...